Use of Bedside Ultrasound in Emergency Department Patients With Concern for Pulmonary Embolism to Reduce CT Imaging

May 19, 2018 updated by: Dorcas Boahema Pinto, Albany Medical College
At most institutions, the average patient with clinical concern for PE(pulmonary embolism) will have a CT angiogram(CTA) with contrast of the lungs performed to evaluate for a clot. However, CTA has risks including contrast- induced allergic reactions and nephropathy, as well as radiation which has been linked to development of cancer later in life. There is literature that has looked at using lower extremity doppler ultrasound first to evaluate for a DVT (deep venous thrombosis) in patients where there is concern for a PE. There is also literature showing that emergency medicine physicians can perform adequate lower extremity compression ultrasounds (LCUS), at the bedside with results similar to that of the ultrasound tech. The goal of this project is to fuse both principles by having emergency medicine physicians perform LCUS at the bedside, to help reduce CTA utilization in the evaluation of PE.

Study Overview

Detailed Description

In this study, the subgroup of hemodynamically stable patients felt to be at moderate to high risk for PE will receive a bilateral LCUS before possible CTA/VQ imaging. The LCUS of the entire proximal leg including the popliteal fossa will be performed by an emergency medicine resident provider in conjunction with their attending. All positive studies will then be confirmed with a second ultrasound by the Albany Medical Center's vascular laboratory service. Patients with confirmed acute positive studies identifying a DVT will be treated for a presumed PE, which is the same treatment as that for the DVT. No CTA will be ordered from the ED. They will be anticoagulated and admitted to the hospital, with further management as per the inpatient hospital team. Patients with a negative emergency department LCUS done by the resident will receive either a CTA or a VQ (ventilation/perfusion) scan as per the initial treatment plan established by the attending physician.

According to this protocol, patients discharged home by default must have had a negative CTA or VQ scan, and so PE was effectively ruled out. Therefore they will not require further follow up after discharge. However, we will follow patients who were admitted throughout their admission course. Through review of medical records, we will take note of any complications such as any issues with starting anticoagulation treatment without a CTA, misdiagnoses, whether a CTA was ordered later as a part of their course and why, and further details.

Study Type

Interventional

Enrollment (Anticipated)

300

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Dorcas B Pinto, MD
  • Phone Number: 518-262-3773
  • Email: PintoD@amc.edu

Study Contact Backup

Study Locations

    • New York
      • Albany, New York, United States, 12208
        • Recruiting
        • Albany Medical Center Department of Emergency Medicine
        • Contact:
        • Contact:
        • Principal Investigator:
          • Dorcas B Pinto, MD
        • Principal Investigator:
          • Beth Cadigan, MD
        • Sub-Investigator:
          • Sean Donovan, MBCHB

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Clinical Concern for PE (moderate to high risk) that warrants imaging of the chest

Exclusion Criteria:

  • Age less than 18
  • nidus for DVT in upper extremity (eg. PICC (peripherally inserted central Cather) line, etc)
  • already anti-coagulated at presentation
  • above the knee- leg cast
  • prisoners
  • DVT ultrasound or CTA prior to presentation
  • Hemodynamically unstable:
  • SBP (systolic blood pressure) <90 for >15min
  • Drop of SBP by at least 40mmHG for >15mins
  • Organ hypoperfusion (eg cold extremities, mental confusion, low urine outpt <30cc/hr, etc
  • need for pressors
  • Other concerns in thorax necessitating inevitable CT chest imaging.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: DIAGNOSTIC
  • Allocation: RANDOMIZED
  • Interventional Model: SEQUENTIAL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Positive lower extremity ultrasound
This group found to to have a deep venous thrombosis on lower extremity ultrasound will not have a CT of the chest ordered from the emergency department, and will be treated for the DVT and presumed PE.
One group may forego a CT angiogram of the chest if they have a positive lower extremity ultrasound. The other group with a negative ultrasound may still require CT angiogram imaging.
Other Names:
  • CT angiogram of the chest
Other: Negative lower extremity ultrasound
This group that does not have a deep venous thrombosis on lower extremity ultrasound will proceed to get the CT of the chest .
One group may forego a CT angiogram of the chest if they have a positive lower extremity ultrasound. The other group with a negative ultrasound may still require CT angiogram imaging.
Other Names:
  • CT angiogram of the chest

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Absolute reduction in CT imaging to diagnose PE
Time Frame: for duration of the study,about 1 year
With the use of lower extremity ultrasound to diagnose DVT, some patients may forego the need for CT imaging while receiving appropriate care/treatment.
for duration of the study,about 1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Potential reduction in CT imaging to diagnose PE
Time Frame: for duration of the study, about 1 year
If a CT is ordered on a patient with a positive lower extremity ultrasound by an inpatient physician later during the admission, we will calculate what the reduction in CT imaging would have been if the protocol had been followed to the end.
for duration of the study, about 1 year
Time to start of treatment
Time Frame: for duration of the study , about 1 year
The use of bedside ultrasound may allow for making a diagnoses more quickly, and therefore potentially starting treatment sooner.
for duration of the study , about 1 year
Cost-analysis
Time Frame: for duration of study, about 1 year
The use of ultrasound may have less cost than using a CT scan
for duration of study, about 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Dorcas B Pinto, MD, Albany Medical College

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 2, 2018

Primary Completion (Anticipated)

February 22, 2019

Study Completion (Anticipated)

February 28, 2019

Study Registration Dates

First Submitted

May 1, 2018

First Submitted That Met QC Criteria

May 19, 2018

First Posted (Actual)

May 22, 2018

Study Record Updates

Last Update Posted (Actual)

May 22, 2018

Last Update Submitted That Met QC Criteria

May 19, 2018

Last Verified

May 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pulmonary Embolism

Clinical Trials on Lower extremity Ultrasound

3
Subscribe